402 Dual Inhibition of the MEK and the PI3K-Akt-mTOR Pathways Using GSK1120212 (or UO126) and Everolimus Overcomes Resistance to MEK Inhibitors Used as Single Agents in Pancreatic Cancer Cells
Saved in:
| Title: | 402 Dual Inhibition of the MEK and the PI3K-Akt-mTOR Pathways Using GSK1120212 (or UO126) and Everolimus Overcomes Resistance to MEK Inhibitors Used as Single Agents in Pancreatic Cancer Cells |
|---|---|
| Authors: | Neuzillet, C., Serova, M., Raballand, A., Astorgues-Xerri, L., Riveiro, M.E., de Gramont, A., Ruszniewski, P., Hammel, P., Faivre, S., Raymond, E. |
| Source: | European Journal of Cancer. Nov2012 Supplement, Vol. 48, p122-122. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
